4TEEN4 Pharmaceuticals
Peter Ruile currently serves as Vice President and Head of Business Development & Licensing at 4TEEN4 Pharmaceuticals since February 2025. Previously, Peter held the position of Vice President of Business Development & Licensing and Head of Business Development at Cardior Pharmaceuticals from February 2019 to February 2025. Peter's career also includes significant roles such as Operations Director for the Global Platform for the Protection of Autoimmune Diabetes (GPPAD) at Helmholtz Zentrum München, and multiple positions at MorphoSys AG, culminating in Senior Director Innovation Capital. Earlier experience includes leadership roles at Ascenion GmbH, ITN GmbH, and HelmholtzZentrum München.
This person is not in any teams